Preclinical studies using immobilized OKT3 to activate human T cells for adoptive immunotherapy: optimal conditions for the proliferation and induction of non-MHC-restricted cytotoxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/8313660

Download in:

View as

General Info

PMID
8313660